Keiichi Ozono

18.0k total citations
432 papers, 10.6k citations indexed

About

Keiichi Ozono is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Keiichi Ozono has authored 432 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Molecular Biology, 106 papers in Genetics and 76 papers in Pathology and Forensic Medicine. Recurrent topics in Keiichi Ozono's work include Vitamin D Research Studies (60 papers), Parathyroid Disorders and Treatments (56 papers) and Alkaline Phosphatase Research Studies (50 papers). Keiichi Ozono is often cited by papers focused on Vitamin D Research Studies (60 papers), Parathyroid Disorders and Treatments (56 papers) and Alkaline Phosphatase Research Studies (50 papers). Keiichi Ozono collaborates with scholars based in Japan, United States and Germany. Keiichi Ozono's co-authors include Toshimi Michigami, Takuo Kubota, Masanobu Kawai, Noriyuki Namba, J. Wesley Pike, Masako Taniike, Sotaro Mushiake, Miwa Yamazaki, Yasuhisa Ohata and Ikuko Mohri and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Keiichi Ozono

413 papers receiving 10.4k citations

Peers

Countries citing papers authored by Keiichi Ozono

Since Specialization

Citations

This map shows the geographic impact of Keiichi Ozono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiichi Ozono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiichi Ozono more than expected).

Fields of papers citing papers by Keiichi Ozono

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiichi Ozono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiichi Ozono. The network helps show where Keiichi Ozono may publish in the future.

Co-authorship network of co-authors of Keiichi Ozono

This figure shows the co-authorship network connecting the top 25 collaborators of Keiichi Ozono. A scholar is included among the top collaborators of Keiichi Ozono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiichi Ozono. Keiichi Ozono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Revisiting the Genetics of Hypophosphatasia 2025 ·Journal of Inherited Metabolic Disease ·Priya S. Kishnani, Catherine Rehder, Keiichi Ozono, Jordi Pérez‐López, Guillermo del Angel, William R. Mowrey, Meena Balasubramanian, Wolfgang Högler, Eric T. Rush	0
2	The Global Hypophosphatasia Registry: lessons learned from a decade of real-world data 2025 ·Orphanet Journal of Rare Diseases ·Priya S. Kishnani, Lothar Seefried, Keiichi Ozono, Gabriel Ángel Martos‐Moreno, Cheryl R. Greenberg, (unknown), Louise M. Burke, William R. Mowrey, Eric T. Rush, Peter R. Ebeling, Wolfgang Högler, Agnès Linglart, Shona Fang, Anna Petryk, Kathryn Dahir	0
3	Prevalence of Comorbid Hyperparathyroidism and Its Association with Renal Dysfunction in Asian Patients with X-Linked Hypophosphatemic Rickets/Osteomalacia 2025 ·Calcified Tissue International ·Nobuaki Ito, Hee Gyung Kang, Toshimi Michigami, Noriyuki Namba, Takuo Kubota, Ayumi Shintani, (unknown), Daijiro Kabata, Haruka Ishii, Yayoi Nishida, Seiji Fukumoto, Keiichi Ozono	0
4	P131: Persistence of growth-promoting effects in infants and toddlers with achondroplasia: Results from a phase II extension study with vosoritide* 2024 ·SHILAP Revista de lepidopterología ·Ravi Savarirayan, William R. Wilcox, Paul Harmatz, J. P. Phillips, Lynda E. Polgreen, Louise Tofts, Keiichi Ozono, Paul Arundel, Melita Irving, Carlos A. Bacino, Donald Basel, (unknown), Joel Charrow, Hiroshi Mochizuki, Yumiko Kotani, Howard M. Saal, (unknown), Andrea Hsiu Ling Low, Elena Fisheleva, Jonathan F. Day	1
5	Effect of Mutation Type on Ectopic Ossification Among Adult Patients With X-Linked Hypophosphatemia 2024 ·Journal of the Endocrine Society ·Hajime Katô, (unknown), Yasuhisa Ohata, (unknown), (unknown), (unknown), (unknown), (unknown), Yuka Kinoshita, Yuki Taniguchi, Hiroshi Kobayashi, Demetrios T. Braddock, Takuo Kubota, Keiichi Ozono, Masaomi Nangaku, Noriko Makita, Nobuaki Ito	2
6	Effectiveness of asfotase alfa for treatment of adults with hypophosphatasia: results from a global registry 2024 ·Orphanet Journal of Rare Diseases ·Priya S. Kishnani, Gabriel Ángel Martos‐Moreno, Agnès Linglart, Anna Petryk, Andrew Messali, Shona Fang, Cheryl R. Greenberg, Keiichi Ozono, Wolfgang Högler, Lothar Seefried, Kathryn Dahir	16
7	Clinical outcomes and medical management of achondroplasia in Japanese children: A retrospective medical record review of clinical data 2024 ·American Journal of Medical Genetics Part A ·(unknown), Taichi Kitaoka, Takuo Kubota, Junko Kanno, Hiroshi Mochizuki, Toshimi Michigami, Kosei Hasegawa, Ikuma Fujiwara, Takashi Hamajima, Daisuke Harada, Y. Seki, Keisuke Nagasaki, Sumito Dateki, Noriyuki Namba, Hirofumi Tokuoka, Jeanne M. Pimenta, (unknown), Keiichi Ozono	3
8	Enhanced antitumor activity of a novel, oral, helper epitope-containing WT1 protein vaccine in a model of murine leukemia 2023 ·BMC Cancer ·(unknown), Yoshiko Hashii, Hiroko Nakajima, Fumihiro Fujiki, Soyoko Morimoto, Jun Nakata, Toshiro Shirakawa, Takane Katayama, Akihiro Tsuboi, Keiichi Ozono	5
9	Clinical Outcomes and Genetic Analyses of Restrictive Cardiomyopathy in Children 2023 ·Circulation Genomic and Precision Medicine ·Hidekazu Ishida, Jun Narita, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kazuhisa Hashimoto, (unknown), Shigetoyo Kogaki, Yuki Kuramoto, (unknown), Yoshihiro Asano, Keiichi Ozono	6
10	An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia 2022 ·Cancer Immunology Immunotherapy ·Natsuki Nakagawa, Yoshiko Hashii, Hisako Kayama, Ryu Okumura, Hiroko Nakajima, (unknown), Soyoko Morimoto, Fumihiro Fujiki, Jun Nakata, Toshiro Shirakawa, Takane Katayama, Kiyoshi Takeda, Akihiro Tsuboi, Keiichi Ozono	14
11	Skeletal dysplasia in adenosine deaminase deficiency 2022 ·Pediatrics International ·(unknown), Takako Miyamura, Yoshiko Hashii, Hirokazu Kanegane, Keiichi Ozono	1
12	Prevalence of Pseudohypoparathyroidism and Nonsurgical Hypoparathyroidism in Japan in 2017: A Nationwide Survey 2022 ·Journal of Epidemiology ·(unknown), Takuo Kubota, Masanori Minagawa, Daisuke Inoue, Seiji Fukumoto, Keiichi Ozono, Yosikazu Nakamura	8
13	Japanese nationwide survey of hypophosphatasia reveals prominent differences in genetic and dental findings between odonto and non-odonto types 2019 ·PLoS ONE ·Rena Okawa, (unknown), Taichi Kitaoka, Takuo Kubota, Atsushi Watanabe, Takeshi Taketani, Toshimi Michigami, Keiichi Ozono, Kazuhiko Nakano	19
14	Assessment criteria for vitamin D deficiency/insufficiency in Japan: proposal by an expert panel supported by the Research Program of Intractable Diseases, Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research and the Japan Endocrine Society [Opinion] 2016 ·Journal of Bone and Mineral Metabolism ·Ryo Okazaki, Keiichi Ozono, Seiji Fukumoto, Daisuke Inoue, Mika Yamauchi, Masanori Minagawa, Toshimi Michigami, Yasuhiro Takeuchi, Toshio Matsumoto, Toshitsugu Sugimoto	77
15	Acromesomelic dysplasia, type maroteaux caused by novel loss‐of‐function mutations of the NPR2 gene: Three case reports 2015 ·American Journal of Medical Genetics Part A ·Wei Wang, Mi Hyun Song, Kohji Miura, Makoto Fujiwara, Nobutoshi Nawa, Yasuhisa Ohata, Taichi Kitaoka, Takuo Kubota, Noriyuki Namba, Dong‐Kyu Jin, Ok Hwa Kim, Keiichi Ozono, Tae‐Joon Cho	23
16	Overgrowth syndrome associated with a gain‐of‐function mutation of the natriuretic peptide receptor 2 (NPR2) gene 2013 ·American Journal of Medical Genetics Part A ·Kohji Miura, Ok‐Hwa Kim, (unknown), Noriyuki Namba, Toshimi Michigami, Won Joon Yoo, In Ho Choi, Keiichi Ozono, Tae‐Joon Cho	63
17	[Bone and joint diseases in children. Phosphaturic hormone, FGF23, and bone metabolism]. 2010 ·PubMed ·Keiichi Ozono	1
18	Prostaglandin D₂-Mediated Microglia/Astrocyte Interaction Enhances Astrogliosis and Demyelination intwitcher 2006 ·Journal of Neuroscience ·Ikuko Mohri, Masako Taniike, Hidetoshi Taniguchi, Takahisa Kanekiyo, Kosuke Aritake, Takashi Inui, Noriko Fukumoto, Naomi Eguchi, Atsuko Kushi, Hitoshi Sasai, Yoshihide Kanaoka, Keiichi Ozono, Shuh Narumiya, Kinuko Suzuki, Yoshihiro Urade	152
19	A congenital mutation of the novel gene LRRC8 causes agammaglobulinemia in humans 2003 ·Journal of Clinical Investigation ·Akihisa Sawada, Yoshihiro Takihara, Ji Yoo Kim, (unknown), Sadao Tokimasa, Hiroyuki Fujisaki, Keiko Kubota, Hiroko Endo, Takashi Onodera, Hideaki Ohta, Keiichi Ozono, Junichi Hara	111
20	Antagonistic Actionsin Vivoof (23S)-25-Dehydro-1α-Hydroxyvitamin D_3-26,23-Lactone on Calcium Metabolism Induced by 1α,25-Dihydroxyvitamin D₃ 2001 ·Endocrinology ·Seiichi Ishizuka, Daishiro Miura, Keiichi Ozono, Manabu Chokki, (unknown), Anthony W. Norman	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact